| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |